CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL EBITDA Margin

EBITDA as a percentage of revenue.

CorVel CorporationNASDAQ: CRVL

EBITDA Margin · Q2 FY2027 · quarter ended Sep 2026

EBITDA Margin narrows to 17.2%

EBITDA Margin was 17.2% in Q2 FY2027, down 1.1 pp from a year earlier. On a trailing-twelve-month basis it was 18.4%, up 0.7 pp year over year. Over 3 fiscal years it widened by 3.0 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
17.2%-2.9 pp QoQ
Last fiscal yearMar 2026
18.2%+1.5 pp YoY
LTMSep 2026
18.4%+0.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.1 pp——
1 year+1.5 pp——
3 years+3.0 pp——
5 years——
10 years——

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
18.2%
Year-over-year change
+1.5pp

EBITDA Margin vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Sep 2026 EBITDA Margin of 18.4% is the 3rd highest of the 4 companies compared; the peer median is 36.3%.
  • Its year-over-year change of +0.7 pp is the 3rd highest of 4, against a peer median of +4.4 pp.
  • Over three fiscal years its change of +3.0 pp compares with a peer median of +17.3 pp.
CRVL Competitors Peer median
EBITDA Margin for CRVL and competitors
Company Period LTM level YoY 3-year change
CTEVClaritev CorporationLTM Mar 202652.9% +109.3 pp+34.6 pp
HQYHealthEquity, Inc.LTM Jul 202636.3% +4.4 pp+17.3 pp
CRVLCorVel CorporationLTM Sep 202618.4% +0.7 pp+3.0 pp
EVHEvolent Health, Inc.LTM Mar 2026-16.7% -18.0 pp-22.5 pp
Peer median (excluding CRVL) 36.3%+4.4 pp+17.3 pp

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue646.23M718.56M795.31M895.59M958.53M
Cost of Revenue494.12M560.3M623.62M685.86M725.66M
Gross Profit152.11M158.26M171.69M209.73M232.86M
Gross Margin23.5%22.0%21.6%23.4%24.3%
Research & Development00000
Selling, General & Admin67.6M73.71M76.59M88.9M89.73B
Operating Expenses67.6M73.71M76.59M88.9M89.73M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
EBITDA108.43M109.68M121.35M150.36M174.9M
EBITDA Margin16.8%15.3%15.3%16.8%18.2%
Operating Income84.51M84.55M95.1M120.82M143.13M
Operating Margin13.1%11.8%12.0%13.5%14.9%
Interest Income00000
Interest Expense00000
Other Income / Expenses00000
Income Before Tax84.51M84.55M95.1M120.82M143.13M
Pre-Tax Margin13.1%11.8%12.0%13.5%14.9%
Income Tax Expense18.1M18.19M18.85M25.66M32.79M
Net Income66.41M66.37M76.25M95.17M110.34M
Net Margin10.3%9.2%9.6%10.6%11.5%
EPS (Basic)1.251.281.481.852.15
EPS (Diluted)1.221.261.471.832.14
Weighted Avg Shares53.26M51.98M51.37M51.39M51.28M
Weighted Avg Shares (Diluted)54.38M52.78M52.04M52.04M51.63M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.